The Power of Placebo in Aromatase Inhibitor-Induced Arthralgia
Researcher found an improvement in aromatase inhibitor-associated arthralgia in both omega-3 fatty acids and placebo treatment.
Researcher found an improvement in aromatase inhibitor-associated arthralgia in both omega-3 fatty acids and placebo treatment.
New treatment modalities are being developed for patients with pancreatic cancer aimed at improving efficacy as well as limiting toxicity.
ABVD and Stanford V treatment regimens show similar efficacy in patients with Hodgkin lymphoma.
Up to 10 percent of ascites diagnoses are related to cancer.
As newer treatment options for peritoneal carcinomatosis are developed, more clinical data is needed to support use in patients with colorectal cancer.
Oncology patients with malnutrition clinically do worse with respect to survival, response to treatment, and adverse events.
Analysis from phase III ENDEAVOR trial showed Kyprolis and dexamethasone superior to Velcade and dexamethasone in relapsed multiple myeloma.
The “antigocoagulation gastrointestinal stress test” could represent a previously under-recognized modality leading to early detection of GI malignancy.
Onset of sorafenib-associated hand-foot skin reactions can be delayed by urea-based cream plus best supportive care in advanced hepatocellular carcinoma.
Chemotherapy can be dosed based on body surface area or body weight, but some studies show up to 40% of obese patients receive lower doses.